386 related articles for article (PubMed ID: 9577953)
1. Angiotensin-converting enzyme inhibitors.
Brown NJ; Vaughan DE
Circulation; 1998 Apr; 97(14):1411-20. PubMed ID: 9577953
[TBL] [Abstract][Full Text] [Related]
2. Reinventing the ACE inhibitors: some old and new implications of ACE inhibition.
Hanif K; Bid HK; Konwar R
Hypertens Res; 2010 Jan; 33(1):11-21. PubMed ID: 19911001
[TBL] [Abstract][Full Text] [Related]
3. Importance of angiotensin-converting enzyme inhibitors in myocardial infarction and congestive heart failure: implications for clinical practice.
Pitt B
Cardiology; 1995; 86 Suppl 1():41-5. PubMed ID: 7614506
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
5. [The effect of angiotensin-converting enzyme inhibitors on the progression of chronic renal failure].
Bernadet-Monrozies P; Rostaing L; Kamar N; Durand D
Presse Med; 2002 Nov; 31(36):1714-20. PubMed ID: 12467154
[TBL] [Abstract][Full Text] [Related]
6. Neurohormonal activation and congestive heart failure: today's experience with ACE inhibitors and rationale for their use.
Sigurdsson A; Swedberg K
Eur Heart J; 1995 Dec; 16 Suppl N():65-72. PubMed ID: 8682064
[TBL] [Abstract][Full Text] [Related]
7. Angiotensin AT-1 receptor antagonism: complementary or alternative to ACE inhibition in cardiovascular and renal disease?
Doggrell SA
Expert Opin Pharmacother; 2002 Nov; 3(11):1543-56. PubMed ID: 12437489
[TBL] [Abstract][Full Text] [Related]
8. [Inhibition of the renin-angiotensin system: ACE inhibitors and angiotensin II receptor blockers].
Pichler M; Klein W; Huber K; Pachinger O
Wien Med Wochenschr; 1996; 146(11):228-31. PubMed ID: 8928520
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction.
Sander GE; McKinnie JJ; Greenberg SS; Giles TD
Prog Cardiovasc Dis; 1999; 41(4):265-300. PubMed ID: 10362349
[TBL] [Abstract][Full Text] [Related]
10. [Current aspects of ACE inhibitor therapy from the cardiologic viewpoint].
Klein W; Eber B; Gasser R; Stoschitzky K; Schumacher M; Fruhwald FM; Zweiker R
Wien Med Wochenschr; 1996; 146(11):221-4. PubMed ID: 8928518
[TBL] [Abstract][Full Text] [Related]
11. Interrupting the renin-angiotensin system: the role of angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of hypertension.
Weber MA
Am J Hypertens; 1999 Dec; 12(12 Pt 3):189S-194S. PubMed ID: 10619571
[TBL] [Abstract][Full Text] [Related]
12. [Angiotensin II receptor blockers--evidence along the cardiovascular continuum].
Zeller A; Battegay E
Praxis (Bern 1994); 2005 Apr; 94(15):581-94. PubMed ID: 15884724
[TBL] [Abstract][Full Text] [Related]
13. The use of ACE inhibitor in cardiovascular disease.
Nasution SA
Acta Med Indones; 2006; 38(1):60-4. PubMed ID: 16479034
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin converting enzyme inhibitor prevents left ventricular remodelling after myocardial infarction in angiotensin II type 1 receptor knockout mice.
Yoshiyama M; Nakamura Y; Omura T; Izumi Y; Matsumoto R; Oda S; Takeuchi K; Kim S; Iwao H; Yoshikawa J
Heart; 2005 Aug; 91(8):1080-5. PubMed ID: 16020603
[TBL] [Abstract][Full Text] [Related]
15. Racial differences in blood pressure response to angiotensin-converting enzyme inhibitors in children: a meta-analysis.
Li JS; Baker-Smith CM; Smith PB; Hasselblad V; Murphy MD; Califf RM; Benjamin DK
Clin Pharmacol Ther; 2008 Sep; 84(3):315-9. PubMed ID: 18548000
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme inhibitors: congestive heart failure and beyond.
Lombardi WL; Litwin SE
Coron Artery Dis; 1999 Sep; 10(6):361-8. PubMed ID: 10474785
[TBL] [Abstract][Full Text] [Related]
17. Using ACE inhibitors appropriately.
Bicket DP
Am Fam Physician; 2002 Aug; 66(3):461-8. PubMed ID: 12182524
[TBL] [Abstract][Full Text] [Related]
18. Quinapril. A reappraisal of its pharmacology and therapeutic efficacy in cardiovascular disorders.
Plosker GL; Sorkin EM
Drugs; 1994 Aug; 48(2):227-52. PubMed ID: 7527326
[TBL] [Abstract][Full Text] [Related]
19. Chronic effects of early started angiotensin converting enzyme inhibition and angiotensin AT1-receptor subtype blockade in rats with myocardial infarction: role of bradykinin.
Hu K; Gaudron P; Anders HJ; Weidemann F; Turschner O; Nahrendorf M; Ertl G
Cardiovasc Res; 1998 Aug; 39(2):401-12. PubMed ID: 9798525
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin converting enzyme inhibitors in perspective: an update.
Burrell LM; Johnston CI
Aust Fam Physician; 1993 Jul; 22(7):1243-7, 1251, 1255. PubMed ID: 8373316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
